Safety of dermatologic medications in pregnancy and lactation: An Update-Part I: Pregnancy

P McMullan, M Yaghi, TM Truong, M Rothe… - Journal of the American …, 2024 - Elsevier
The breadth of therapeutic options for the management of dermatologic skin conditions
continues to expand rapidly as exemplified by biologics and small molecule drug …

Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives

M Munera-Campos, JM Carrascosa - American Journal of Clinical …, 2024 - Springer
Hormonal and immunologic changes during pregnancy can contribute to the development of
different dermatoses, the most common of which is atopic eruption of pregnancy (AEP). Of …

[HTML][HTML] [Translated article] Janus Kinase Inhibitors in Atopic Dermatitis: New Perspectives

M Munera-Campos, JM Carrascosa - Actas dermo-sifiliograficas, 2023 - Elsevier
Abstract The JAK/STAT (Janus kinase/signal transducer and activator of transcription)
pathway is an essential final step in the signaling process of most interleukins with a critical …

[HTML][HTML] Inhibidores de JAK en dermatitis atópica, nuevas perspectivas

M Munera-Campos, JM Carrascosa - Actas Dermo-Sifiliográficas, 2023 - Elsevier
La vía Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) es
esencial en la señalización final de una gran mayoría de interleucinas (IL) fundamentales …

Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate‐to‐severe atopic dermatitis: A nationwide retrospective cohort …

G Avallone, F Cavallo, A Tancredi… - Journal of the …, 2024 - Wiley Online Library
Background There is limited epidemiological evidence on outcomes associated with
dupilumab exposure during pregnancy; monitoring pregnancy outcomes in large …